Benzinga | Apr 13, 2021 08:01AM EDT

Acutus Medical Announces FDA Clearance Of AcQCross Suite Of Universal Transseptal Crossing Devices

Acutus Medical, Inc. ("Acutus") (NASDAQ:AFIB), an arrhythmia management company focused on improving the way cardiac arrhythmias are diagnosed and treated, today announced the FDA clearance of the AcQCross(tm) family of universal transseptal crossing devices. This is the first and only transseptal puncture system specifically engineered to pair and mate seamlessly with Acutus' own suite of sheaths and with sheaths sold by other manufacturers. In the United States, there are over 300,000 electrophysiology (EP) and structural heart procedures per year involving the use of transeptal crossing devices1,2,3. The company will initiate its full US commercial launch of AcQCross in the coming weeks.